Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2000 May;53(5):362–366. doi: 10.1136/jcp.53.5.362

Aspergillus antigen testing in bone marrow transplant recipients

E Williamson 1, D Oliver 1, E Johnson 1, A Foot 1, D Marks 1, D Warnock 1
PMCID: PMC1731188  PMID: 10889818

Abstract

Aims—To assess the clinical usefulness of a commercial aspergillus antigen enzyme linked immunosorbent assay (ELISA) in the diagnosis of invasive aspergillosis (IA) in bone marrow transplant recipients, and to compare it with a commercial latex agglutination (LA) test.

Methods—In total, 2026 serum samples from 104 bone marrow transplant recipients were tested. These comprised 67 sera from seven patients who had died with confirmed IA, 268 sera from nine patients who had died with suspected IA, and 1691 sera from 88 patients with no clinical, radiological, or microbiological signs of IA.

Results—The ELISA was more sensitive than the LA test. All patients who were ELISA positive were also LA positive, and a positive LA result never preceded a positive ELISA. Twelve of 16 patients with confirmed or suspected IA were ELISA positive on two or more occasions, compared with 10 of 15 who were LA positive. ELISA was positive before LA in five patients (range, 2–14 days), and became positive on the same day in the remainder. Aspergillus antigen was detected by ELISA a median of 15 days before death (range, 4–233). Clinical and/or radiological evidence of IA was noted in all patients, and a positive ELISA was never the sole criterion for introduction of antifungal treatment. Two samples (one from each of two patients without IA) gave false positive results.

Conclusions—The aspergillus ELISA is a specific indicator of invasive aspergillosis if the criterion of two positive samples is required to confirm the diagnosis. However, the test is insufficiently sensitive to diagnose aspergillosis before other symptoms or signs are apparent, and hence is unlikely to lead to earlier initiation of antifungal treatment. It is therefore unsuitable for screening of asymptomatic patients at risk of invasive aspergillosis, but does have a useful role in confirming the diagnosis in symptomatic patients.

Key Words: invasive aspergillosis • aspergillus antigen • Platelia enzyme linked immunosorbent assay

Full Text

The Full Text of this article is available as a PDF (243.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A. R., Workman S. ANA-negative systemic lupus erythematosus. Clin Exp Dermatol. 1983 Jul;8(4):369–377. doi: 10.1111/j.1365-2230.1983.tb01795.x. [DOI] [PubMed] [Google Scholar]
  2. Aisner J., Wiernik P. H., Schimpff S. C. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med. 1977 May;86(5):539–543. doi: 10.7326/0003-4819-86-5-539. [DOI] [PubMed] [Google Scholar]
  3. Anaissie E. J., Kontoyiannis D. P., O'Brien S., Kantarjian H., Robertson L., Lerner S., Keating M. J. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med. 1998 Oct 1;129(7):559–566. doi: 10.7326/0003-4819-129-7-199810010-00010. [DOI] [PubMed] [Google Scholar]
  4. Ansorg R., Heintschel von Heinegg E., Rath P. M. Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):582–589. doi: 10.1007/BF01971310. [DOI] [PubMed] [Google Scholar]
  5. Bastie J. N., Cazals-Hatem D., Daniel M. T., D'Agay M. F., Rabian C., Glaisner S., Noel-Walter M. P., Dabout D., Flandrin G., Dombret H. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment. Leuk Lymphoma. 1999 Nov;35(5-6):555–565. doi: 10.1080/10428199909169620. [DOI] [PubMed] [Google Scholar]
  6. Bretagne S., Costa J. M., Bart-Delabesse E., Dhédin N., Rieux C., Cordonnier C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis. 1998 Jun;26(6):1407–1412. doi: 10.1086/516343. [DOI] [PubMed] [Google Scholar]
  7. Bretagne S., Marmorat-Khuong A., Kuentz M., Latgé J. P., Bart-Delabesse E., Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect. 1997 Jul;35(1):7–15. doi: 10.1016/s0163-4453(97)90833-1. [DOI] [PubMed] [Google Scholar]
  8. Byrd J. C., Hargis J. B., Kester K. E., Hospenthal D. R., Knutson S. W., Diehl L. F. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis. Am J Hematol. 1995 Jun;49(2):135–142. doi: 10.1002/ajh.2830490207. [DOI] [PubMed] [Google Scholar]
  9. Caillot D., Casasnovas O., Bernard A., Couaillier J. F., Durand C., Cuisenier B., Solary E., Piard F., Petrella T., Bonnin A. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997 Jan;15(1):139–147. doi: 10.1200/JCO.1997.15.1.139. [DOI] [PubMed] [Google Scholar]
  10. Colvin R. B., Cohen A. H., Saiontz C., Bonsib S., Buick M., Burke B., Carter S., Cavallo T., Haas M., Lindblad A. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol. 1997 Dec;8(12):1930–1941. doi: 10.1681/ASN.V8121930. [DOI] [PubMed] [Google Scholar]
  11. Corwin H. L., Schwartz M. M., Lewis E. J. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol. 1988;8(2):85–89. doi: 10.1159/000167563. [DOI] [PubMed] [Google Scholar]
  12. Damron D. J., Warren J. W., Chippendale G. R., Tenney J. H. Do clinical microbiology laboratories report complete bacteriology in urine from patients with long-term urinary catheters? J Clin Microbiol. 1986 Sep;24(3):400–404. doi: 10.1128/jcm.24.3.400-404.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dealler S. F., Belfield P. W., Bedford M., Whitley A. J., Mulley G. P. Purple urine bags. J Urol. 1989 Sep;142(3):769–770. doi: 10.1016/s0022-5347(17)38882-1. [DOI] [PubMed] [Google Scholar]
  14. Dealler S. F., Hawkey P. M., Millar M. R. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J Clin Microbiol. 1988 Oct;26(10):2152–2156. doi: 10.1128/jcm.26.10.2152-2156.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Denning D. W. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis. 1996 Sep;23(3):608–615. doi: 10.1093/clinids/23.3.608. [DOI] [PubMed] [Google Scholar]
  16. Dupont B., Huber M., Kim S. J., Bennett J. E. Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. J Infect Dis. 1987 Jan;155(1):1–11. doi: 10.1093/infdis/155.1.1. [DOI] [PubMed] [Google Scholar]
  17. Fisher B. D., Armstrong D., Yu B., Gold J. W. Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med. 1981 Oct;71(4):571–577. doi: 10.1016/0002-9343(81)90208-4. [DOI] [PubMed] [Google Scholar]
  18. Fujita S., Matsubara F., Matsuda T. Demonstration of antigenemia in patients with invasive aspergillosis by biotin-streptavidin enzyme-linked immunosorbent assay. J Lab Clin Med. 1988 Oct;112(4):464–470. [PubMed] [Google Scholar]
  19. Furness P. N. Acp. Best practice no 160. Renal biopsy specimens. J Clin Pathol. 2000 Jun;53(6):433–438. doi: 10.1136/jcp.53.6.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Furness P. N. Acp. Best practice no 160. Renal biopsy specimens. J Clin Pathol. 2000 Jun;53(6):433–438. doi: 10.1136/jcp.53.6.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Furness P. N., Boyd S. Electron microscopy and immunocytochemistry in the assessment of renal biopsy specimens: actual and optimal practice. J Clin Pathol. 1996 Mar;49(3):233–237. doi: 10.1136/jcp.49.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Haynes K., Rogers T. R. Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):670–674. doi: 10.1007/BF01973998. [DOI] [PubMed] [Google Scholar]
  23. Homburger H. A. Cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc. 1995 Feb;70(2):183–184. doi: 10.4065/70.2.183. [DOI] [PubMed] [Google Scholar]
  24. Hopwood V., Johnson E. M., Cornish J. M., Foot A. B., Evans E. G., Warnock D. W. Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol. 1995 Mar;48(3):210–213. doi: 10.1136/jcp.48.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ioannidis J. P., Cappelleri J. C., Skolnik P. R., Lau J., Sacks H. S. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med. 1996 Jan 22;156(2):177–188. [PubMed] [Google Scholar]
  26. Ishida T., Ogura S., Kawakami Y. [Five cases of purple urine bag syndrome in a geriatric ward]. Nihon Ronen Igakkai Zasshi. 1999 Nov;36(11):826–829. doi: 10.3143/geriatrics.36.826. [DOI] [PubMed] [Google Scholar]
  27. Johnson T. M., Kurup V. P., Resnick A., Ash R. C., Fink J. N., Kalbfleisch J. Detection of circulating Aspergillus fumigatus antigen in bone marrow transplant patients. J Lab Clin Med. 1989 Dec;114(6):700–707. [PubMed] [Google Scholar]
  28. Kawamura S., Maesaki S., Noda T., Hirakata Y., Tomono K., Tashiro T., Kohno S. Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis. J Clin Microbiol. 1999 Jan;37(1):218–220. doi: 10.1128/jcm.37.1.218-220.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kuhlman J. E., Fishman E. K., Siegelman S. S. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985 Dec;157(3):611–614. doi: 10.1148/radiology.157.3.3864189. [DOI] [PubMed] [Google Scholar]
  30. Levy H., Horak D. A., Tegtmeier B. R., Yokota S. B., Forman S. J. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med. 1992 May;86(3):243–248. doi: 10.1016/s0954-6111(06)80062-4. [DOI] [PubMed] [Google Scholar]
  31. Lustmann J., Regev E., Melamed Y. Sialolithiasis. A survey on 245 patients and a review of the literature. Int J Oral Maxillofac Surg. 1990 Jun;19(3):135–138. doi: 10.1016/s0901-5027(05)80127-4. [DOI] [PubMed] [Google Scholar]
  32. Malleson P. N., Sailer M., Mackinnon M. J. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child. 1997 Oct;77(4):299–304. doi: 10.1136/adc.77.4.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Manoussakis M. N., Garalea K. L., Tzioufas A. G., Moutsopoulos H. M. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera. Clin Rheumatol. 1988 Dec;7(4):465–469. [PubMed] [Google Scholar]
  34. Manso E., Montillo M., De Sio G., D'Amico S., Discepoli G., Leoni P. Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):756–760. doi: 10.1007/BF02276061. [DOI] [PubMed] [Google Scholar]
  35. Martín Peña F., Alonso Treceño J. L., Escapa Garrachón J., Capa F. Cálculo gigante de glándula submaxilar. Acta Otorrinolaringol Esp. 1990 Jul-Aug;41(4):265–267. [PubMed] [Google Scholar]
  36. Matsuo H., Ishibashi T., Araki C., Sakamaki H., Mazume H., Ueki Y., Miyake S., Tominaga Y., Toyomura K. [Report of three cases of purple urine bag syndrome which occurred with a combination of both E. coli and M. morganii]. Kansenshogaku Zasshi. 1993 May;67(5):487–490. doi: 10.11150/kansenshogakuzasshi1970.67.487. [DOI] [PubMed] [Google Scholar]
  37. McWhinney P. H., Kibbler C. C., Hamon M. D., Smith O. P., Gandhi L., Berger L. A., Walesby R. K., Hoffbrand A. V., Prentice H. G. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis. 1993 Sep;17(3):397–404. doi: 10.1093/clinids/17.3.397. [DOI] [PubMed] [Google Scholar]
  38. Morrison V. A., Haake R. J., Weisdorf D. J. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med. 1994 Jun;96(6):497–503. doi: 10.1016/0002-9343(94)90088-4. [DOI] [PubMed] [Google Scholar]
  39. Nakopoulou L. L., Alexiadou A., Theodoropoulos G. E., Lazaris A. C., Tzonou A., Keramopoulos A. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. J Pathol. 1996 May;179(1):31–38. doi: 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  40. Nancollas G. H., Johnsson M. A. Calculus formation and inhibition. Adv Dent Res. 1994 Jul;8(2):307–311. doi: 10.1177/08959374940080022601. [DOI] [PubMed] [Google Scholar]
  41. Pearson J. M., McWilliam L. J., Coyne J. D., Curry A. Value of electron microscopy in diagnosis of renal disease. J Clin Pathol. 1994 Feb;47(2):126–128. doi: 10.1136/jcp.47.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Racusen L. C., Solez K., Colvin R. B., Bonsib S. M., Castro M. C., Cavallo T., Croker B. P., Demetris A. J., Drachenberg C. B., Fogo A. B. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999 Feb;55(2):713–723. doi: 10.1046/j.1523-1755.1999.00299.x. [DOI] [PubMed] [Google Scholar]
  43. Rogers T. R., Haynes K. A., Barnes R. A. Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet. 1990 Nov 17;336(8725):1210–1213. doi: 10.1016/0140-6736(90)92831-2. [DOI] [PubMed] [Google Scholar]
  44. Rohrlich P., Sarfati J., Mariani P., Duval M., Carol A., Saint-Martin C., Bingen E., Latge J. P., Vilmer E. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J. 1996 Mar;15(3):232–237. doi: 10.1097/00006454-199603000-00011. [DOI] [PubMed] [Google Scholar]
  45. Sabetta J. R., Miniter P., Andriole V. T. The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J Infect Dis. 1985 Nov;152(5):946–953. doi: 10.1093/infdis/152.5.946. [DOI] [PubMed] [Google Scholar]
  46. Silva F. G., Pirani C. L. Electron microscopic study of medical diseases of the kidney: update--1988. Mod Pathol. 1988 Jul;1(4):292–315. [PubMed] [Google Scholar]
  47. Stynen D., Goris A., Sarfati J., Latgé J. P. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol. 1995 Feb;33(2):497–500. doi: 10.1128/jcm.33.2.497-500.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Stynen D., Sarfati J., Goris A., Prévost M. C., Lesourd M., Kamphuis H., Darras V., Latgé J. P. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun. 1992 Jun;60(6):2237–2245. doi: 10.1128/iai.60.6.2237-2245.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sulahian A., Tabouret M., Ribaud P., Sarfati J., Gluckman E., Latgé J. P., Derouin F. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis. 1996 Feb;15(2):139–145. doi: 10.1007/BF01591487. [DOI] [PubMed] [Google Scholar]
  50. Talbot G. H., Weiner M. H., Gerson S. L., Provencher M., Hurwitz S. Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. J Infect Dis. 1987 Jan;155(1):12–27. doi: 10.1093/infdis/155.1.12. [DOI] [PubMed] [Google Scholar]
  51. Verweij P. E., Rijs A. J., De Pauw B. E., Horrevorts A. M., Hoogkamp-Korstanje J. A., Meis J. F. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol. 1995 May;48(5):474–476. doi: 10.1136/jcp.48.5.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Verweij P. E., Stynen D., Rijs A. J., de Pauw B. E., Hoogkamp-Korstanje J. A., Meis J. F. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol. 1995 Jul;33(7):1912–1914. doi: 10.1128/jcm.33.7.1912-1914.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Weinberger A., Sperling O., De Vries A. Calcium and inorganic phosphate in saliva of patients with primary hyperparathyroidism. Clin Chim Acta. 1974 Jan 19;50(1):5–7. doi: 10.1016/0009-8981(74)90070-9. [DOI] [PubMed] [Google Scholar]
  54. Weiner M. H., Talbot G. H., Gerson S. L., Filice G., Cassileth P. A. Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials. Ann Intern Med. 1983 Dec;99(6):777–782. doi: 10.7326/0003-4819-99-6-777. [DOI] [PubMed] [Google Scholar]
  55. Westhofen M., Schäfer H., Seifert G. Calcium redistribution, calcification and stone formation in the parotid gland during experimental stimulation and hypercalcaemia. Cytochemical and X-ray microanalytical investigations. Virchows Arch A Pathol Anat Histopathol. 1984;402(4):425–438. doi: 10.1007/BF00734639. [DOI] [PubMed] [Google Scholar]
  56. Williamson E. C., Millar M. R., Steward C. G., Cornish J. M., Foot A. B., Oakhill A., Pamphilon D. H., Reeves B., Caul E. O., Warnock D. W. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol. 1999 Mar;104(3):560–568. doi: 10.1046/j.1365-2141.1999.01229.x. [DOI] [PubMed] [Google Scholar]
  57. Wilson E. V., Hearn V. M., Mackenzie D. W. Evaluation of a test to detect circulating Aspergillus fumigatus antigen in a survey of immunocompromised patients with proven or suspected invasive disease. J Med Vet Mycol. 1987 Dec;25(6):365–375. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES